Skip to content

Clinical trials

Phase 2/3 Cystic Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Phase 2/3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20041
20153
20181
20191
20212
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Withdrawn3
Terminated2
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Minnesota3
AlgiPharma AS1
Assistance Publique - Hôpitaux de Paris1
Bambino Gesù Hospital and Research Institute1
Bayside Health1
Children's Hospital Los Angeles1
Heba Omara1
Julius-Maximilians University1
National Jewish Health1
Targeted Genetics Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis15
Abdominal Pain1
Aspergillosis1
Digestive System Diseases1
Genetic Diseases, Inborn1
Hypercapnia1
Lung Diseases1
Pancreatic Diseases1
Pathologic Processes1
Reinfection1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.